Navigation Links
US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft Medical
Date:3/26/2009

EDINBURGH, Scotland, March 26 /PRNewswire/ -- On March 23, 2009 the United States Patent and Trademark Office ("USPTO") issued a Non-Final Action Closing Prosecution in the ongoing re-examination of Verathon, Inc.'s United States Patent Number 6,543,447. Aircraft Medical, Ltd. filed the request for the re-examination of this patent in 2006 following litigation (currently on hold) that Verathon initiated against Aircraft.

The new Action from the USPTO has rejected 393 claims that Verathon introduced during the re-examination procedure on grounds that they had impermissibly enlarged the scope of the patent. The remaining 19 claims that have been characterized as "patentable" have been substantially limited in scope compared to the original claims. This is not a final decision and Aircraft believes that the decision to uphold these limited remaining claims will be overturned on appeal.

Aircraft believes that this severe limiting of the claims represents a significant setback for Verathon and that the USPTO's characterization of even the remaining claims as "patentable" will be reversed in further proceedings. Aircraft maintains its position that none of its products fall within either the original or amended claims of Verathon's US Patent Number 6,543,447.

Background

Aircraft Medical is the manufacturer of the McGrath(R) Series 5, the world's first fully portable video laryngoscope. Its compactness, and a cable free design, means the life saving benefits of video laryngoscope technology can fit in the pocket of a paramedic or mobile user. As a result, it is immediately available for use in potentially life threatening cases. The McGrath(R) Series 5 is leading the growth of the portable video laryngoscope market with distribution in North America, Europe and Australasia. Matt McGrath, Aircraft Medical's CEO, was last year named "Young Scot of the Year" by the Institute of Contemporary Scotland in recognition of the invention of McGrath(R) Series 5 and its advancement of healthcare and subsequent international success.

    Contact:
    Financial Dynamics
    Jonathan Birt: +44(0)207-269-7205
    John Dineen: +44(0)207-269-7205



'/>"/>
SOURCE Aircraft Medical Limited
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Last week, Callan Capital, an integrated wealth management ... The Future of San Diego Life Science event at the Estancia La Jolla Resort ... the event with speakers Dr. Rich Heyman, former CEO of Aragon and Seragon, and ...
(Date:5/23/2016)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of $0.24 per share ... stockholders of record as of the close of business on ... approval of the Board of Directors and may be adjusted ...
(Date:5/23/2016)... ... May 23, 2016 , ... Foresight Institute , ... the winners for the 2015 Foresight Institute Feynman Prizes. , These prestigious ... categories, one for experiment and the other for theory in nanotechnology. Prof. Markus ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A ... offer a new way to treat the disease. Surviving Mesothelioma has just posted an ... Scientists from several Korean institutions based their mesothelioma study on the fact the Manumycin ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
Breaking Biology News(10 mins):